VERTEX PHARMACEUTICALS INC / MA Stockholders' Equity 2007-2026 | VRTX
What is stockholders' equity?
Stockholders' equity can be defined as total assets minus total liabilities, representing the owners' residual interest in the company after all debts are paid.
What is VERTEX PHARMACEUTICALS INC / MA's current stockholders' equity?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual stockholders' equity for 2025 was $18.67B, a 13.75% increase from 2024. VERTEX PHARMACEUTICALS INC / MA stockholders' equity for the quarter ending March 31, 2026 was $19.36B.
What was VERTEX PHARMACEUTICALS INC / MA's stockholders' equity in 2024?
VERTEX PHARMACEUTICALS INC / MA annual stockholders' equity for 2024 was $16.41B, a 6.66% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's stockholders' equity in 2023?
VERTEX PHARMACEUTICALS INC / MA annual stockholders' equity for 2023 was $17.58B, a 26.36% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year stockholders' equity CAGR?
VERTEX PHARMACEUTICALS INC / MA stockholders' equity grew at a compound annual growth rate (CAGR) of 16.53% from FY2020 to FY2025, going from $8.69B to $18.67B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $18.67B | +13.7% | 10-K |
| FY2024 | $16.41B | -6.7% | 10-K |
| FY2023 | $17.58B | +26.4% | 10-K |
| FY2022 | $13.91B | +37.7% | 10-K |
| FY2021 | $10.10B | +16.3% | 10-K |
| FY2020 | $8.69B | +42.8% | 10-K |
| FY2019 | $6.09B | +37.2% | 10-K |
| FY2018 | $4.44B | +117.2% | 10-K |
| FY2017 | $2.04B | +52.6% | 10-K |
| FY2016 | $1.34B | +22.4% | 10-K |
| FY2015 | $1.09B | -0.2% | 10-K |
| FY2014 | $1.10B | -19.2% | 10-K |
| FY2013 | $1.36B | +13.4% | 10-K |
| FY2012 | $1.20B | +28.8% | 10-K |
| FY2011 | $928.5M | +84.2% | 10-K |
| FY2010 | $504.0M | -54.0% | 10-K |
| FY2009 | $1.10B | +359.0% | 10-K |
| FY2008 | $238.9M | -12.0% | 10-K |
| FY2007 | $271.3M | - | 10-K |